{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:35:46Z","timestamp":1790786146400,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00CA218885"],"award-info":[{"award-number":["R00CA218885"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA258730"],"award-info":[{"award-number":["R37CA258730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA292949"],"award-info":[{"award-number":["R01CA292949"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA288820"],"award-info":[{"award-number":["R01CA288820"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["P30CA016359"],"award-info":[{"award-number":["P30CA016359"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["17YOUN12"],"award-info":[{"award-number":["17YOUN12"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["25CHAL05"],"award-info":[{"award-number":["25CHAL05"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH21-1-0520"],"award-info":[{"award-number":["W81XWH21-1-0520"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-1-0411"],"award-info":[{"award-number":["W81XWH-18-1-0411"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR170050"],"award-info":[{"award-number":["RR170050"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP220473"],"award-info":[{"award-number":["RP220473"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.canlet.2026.218465","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:09:05Z","timestamp":1774714145000},"page":"218465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["HOX code\u2013based stratification reveals RUNX1T1\u2013HDAC reprogramming as a targetable driver of lineage plasticity across cancers"],"prefix":"10.1016","volume":"648","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9019-1739","authenticated-orcid":false,"given":"Yuyin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4931-1403","authenticated-orcid":false,"given":"Siyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Yijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Eun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assma","family":"Alrefai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anfeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8397-311X","authenticated-orcid":false,"given":"Yaru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Yi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-0896","authenticated-orcid":false,"given":"Ping","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.canlet.2026.218465_bib1","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1158\/1078-0432.CCR-19-1423","article-title":"The role of lineage plasticity in prostate cancer therapy resistance","volume":"25","author":"Beltran","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2026.218465_bib2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","article-title":"Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance","volume":"3","author":"Deng","year":"2022","journal-title":"Nat. Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2026.218465_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/pgs-2017-0039","article-title":"Understanding cancer lineage plasticity: reversing therapeutic resistance in metastatic prostate cancer","volume":"18","author":"Ellis","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"6320","key":"10.1016\/j.canlet.2026.218465_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"issue":"6320","key":"10.1016\/j.canlet.2026.218465_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.canlet.2026.218465_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41588-019-0554-0","article-title":"ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer","volume":"52","author":"Xu","year":"2020","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.canlet.2026.218465_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccell.2020.03.001","article-title":"Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-Targeted therapy via chromatin dysregulation","volume":"37","author":"Zhang","year":"2020","journal-title":"Cancer Cell"},{"issue":"6410","key":"10.1016\/j.canlet.2026.218465_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aat5749","article-title":"Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage","volume":"362","author":"Park","year":"2018","journal-title":"Science"},{"issue":"7047","key":"10.1016\/j.canlet.2026.218465_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"issue":"75","key":"10.1016\/j.canlet.2026.218465_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.canlet.2026.218465_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41422-025-01180-x","article-title":"Lineage plasticity and histological transformation: tumor histology as a spectrum","volume":"35","author":"Li","year":"2025","journal-title":"Cell Res."},{"issue":"18","key":"10.1016\/j.canlet.2026.218465_bib12","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1158\/0008-5472.CAN-23-2260","article-title":"The critical interplay of CAF plasticity and resistance in prostate cancer","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218465_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215901","article-title":"Lineage plasticity in prostate cancer: looking beyond intrinsic alterations","volume":"548","author":"Ferguson","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218465_bib14","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.canlet.2026.218465_bib15","first-page":"271","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.canlet.2026.218465_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMoa1405095","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.canlet.2026.218465_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1209096","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.canlet.2026.218465_bib18","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","article-title":"Apalutamide treatment and metastasis-free survival in prostate cancer","volume":"378","author":"Smith","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.canlet.2026.218465_bib19","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/ERC-20-0272","article-title":"Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview","volume":"28","author":"Blatt","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"10.1016\/j.canlet.2026.218465_bib20","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","article-title":"The transcriptional and epigenetic landscape of cancer cell lineage plasticity","volume":"13","author":"Davies","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218465_bib21","article-title":"Prostate luminal cell plasticity and cancer","volume":"611","author":"Williams","year":"2024","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.canlet.2026.218465_bib22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jtho.2019.06.002","article-title":"Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes","volume":"14","author":"Offin","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218465_bib23","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1158\/2159-8290.CD-23-0539","article-title":"ZNF397 deficiency triggers TET2-Driven lineage plasticity and AR-Targeted therapy resistance in prostate cancer","volume":"14","author":"Xu","year":"2024","journal-title":"Cancer Discov."},{"issue":"39","key":"10.1016\/j.canlet.2026.218465_bib24","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1038\/s41388-021-01982-4","article-title":"Going beyond Polycomb: EZH2 functions in prostate cancer","volume":"40","author":"Park","year":"2021","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.canlet.2026.218465_bib25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.molcel.2020.10.033","article-title":"Impact of lineage plasticity to and from a neuroendocrine phenotype on progression and response in prostate and lung cancers","volume":"80","author":"Rubin","year":"2020","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218465_bib26","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1038\/s41467-022-29963-5","article-title":"ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer","volume":"13","author":"Nouruzi","year":"2022","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.canlet.2026.218465_bib27","doi-asserted-by":"crossref","first-page":"E4179","DOI":"10.1073\/pnas.1719168115","article-title":"LSD1 activates a lethal prostate cancer gene network independently of its demethylase function","volume":"115","author":"Sehrawat","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.canlet.2026.218465_bib28","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1158\/1078-0432.CCR-17-3571","article-title":"Targeting bromodomain and extra-terminal (BET) family proteins in castration-resistant prostate cancer (CRPC)","volume":"24","author":"Welti","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.canlet.2026.218465_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218465_bib30","first-page":"2020","article-title":"Role of Specialized mSWI\/SNF complexes in prostate cancer lineage plasticity","author":"Cyrta","year":"2020","journal-title":"bioRxiv"},{"issue":"9","key":"10.1016\/j.canlet.2026.218465_bib31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41556-021-00743-5","article-title":"An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer","volume":"23","author":"Davies","year":"2021","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218465_bib32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s43018-021-00185-w","article-title":"EZH2 inhibition activates a dsRNA\u2013STING\u2013interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer","volume":"2","author":"Morel","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218465_bib33","article-title":"Notch as a driver of lineage plasticity and therapeutic target in enzalutamide-resistant prostate cancer","volume":"29","author":"Jiang","year":"2025","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.canlet.2026.218465_bib34","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ccell.2023.06.010","article-title":"Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.canlet.2026.218465_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41388-023-02890-5","article-title":"UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance","volume":"43","author":"Rodriguez Tirado","year":"2024","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2026.218465_bib36","doi-asserted-by":"crossref","DOI":"10.1242\/dev.192476","article-title":"Hox genes in development and beyond","volume":"150","author":"Hubert","year":"2023","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.canlet.2026.218465_bib37","first-page":"23","article-title":"HOX genes: seductive science, mysterious mechanisms","volume":"75","author":"Lappin","year":"2006","journal-title":"Ulst. Med. J."},{"issue":"1","key":"10.1016\/j.canlet.2026.218465_bib38","article-title":"Neuroendocrine prostate cancer has distinctive, non-prostatic HOX code that is represented by the loss of HOXB13 expression","volume":"11","author":"Cheng","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218465_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216808","article-title":"PCTA, a pan-cancer cell line transcriptome atlas","volume":"588","author":"Cheng","year":"2024","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.canlet.2026.218465_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/pros.24448","article-title":"CTPC, a combined transcriptome data set of human prostate cancer cell lines","volume":"83","author":"Cheng","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2026.218465_bib40","article-title":"Systematic multi-omics investigation of androgen receptor driven gene expression and epigenetics changes in prostate cancer","volume":"23","author":"Li","year":"2024","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.canlet.2026.218465_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2559.2010.03568.x","article-title":"Breast cancer precursors revisited: molecular features and progression pathways","volume":"57","author":"Lopez-Garcia","year":"2010","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.canlet.2026.218465_bib42","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/pbc.24481","article-title":"Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes","volume":"60","author":"Birks","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2026.218465_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061795","article-title":"Deregulated gene expression profiles and regulatory networks in adult and pediatric RUNX1\/RUNX1T1-Positive AML patients","volume":"15","author":"Kanellou","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.canlet.2026.218465_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0609.2009.01371.x","article-title":"Persistent altered fusion transcript splicing identifies RUNX1-RUNX1T1+ AML patients likely to relapse","volume":"84","author":"Ommen","year":"2010","journal-title":"Eur. J. Haematol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218465_bib45","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/s41588-025-02265-4","article-title":"NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling","volume":"57","author":"Lu","year":"2025","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2026.218465_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41698-024-00667-x","article-title":"Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis","volume":"8","author":"Cheng","year":"2024","journal-title":"npj Precis. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:31:13Z","timestamp":1776349873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S0304383526002284"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218465","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HOX code\u2013based stratification reveals RUNX1T1\u2013HDAC reprogramming as a targetable driver of lineage plasticity across cancers","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218465"}}